Contact:

Email: OptiEDGE@gmx.com

WhatsApp: +1 504 975 3349

ABOUT US:

Dr. Petra Rocic, PhD has 20+ years of experience with preparation and editing, as well as conceptual and graphic design of written and oral scientific presentations and other documents within the context of academic institutions and scientific writing/editing companies.

Scientific Publications – Extensive experience in writing, editing, and publishing of original research articles, editorial commentaries, reviews and academic book chapters (h-index – 25, with over 2,000 citations; list of published articles at https://www.ncbi.nlm.nih.gov/pubmed/?term=rocic+p.
Grants – 20 years of continuous grant funding from the American Heart Association (AHA) and the National Institutes of Health (NIH NHLBI); extensive experience with AHA, NIH NHLBI and SBIR/STTR grant writing and editing; grant writing consultant for scientific writing/editing company (provide content expertise and conceptual input as needed, in addition to style editing)
Scientific Review – Over 15 years of experience with peer review as member of grant review committees of the AHA, NIH and international funding agencies; 20+ years of experience of peer manuscript review as member of Editorial Boards of Circulation Research, Microcirculation and the American Journal of Physiology: Heart and Circulatory Physiology
Scientific Communication – Over 20 years of experience with preparation of scientific and medical educational material using various media, as well as presentation delivery to medical and graduate students, physicians and pharmaceutical company representatives in classroom settings, at national and international meetings, and in a variety of other venues
Scientific and Medical Illustration – Extensive experience with PowerPoint slide deck design and development and design of graphics for biomedical applications in general (designed logos, slide decks, website graphics and brochures for academic institutions and scientific writing/editing companies)
Regulatory Agencies – Extensive experience with writing and review of regulated components of Phase II SBIR/STTR applications (extensive toxicology studies to enable IND submission), and regulatory components which accompany most grant applications, including: IRB, IACUC and IBC protocols.